RT
Radhika Tripuraneni
CDO at Prothena
View Radhika's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
CDO
Present
Company Details
51-200 Employees
Prothena is a late-stage clinical biotechnology company with expertise in protein dysregulation and a diverse pipeline of novel investigational therapies for neurodegenerative and rare peripheral amyloid diseases. We are committed to developing novel and transformative medicines to create a better future for people in critical need of new treatment options. Our product portfolio is designed to make a significant impact on neurodegenerative and rare peripheral amyloid diseases, which affect millions of people and their families worldwide. We leverage insights around neurological dysfunction and the biology of misfolded proteins to develop novel therapeutic solutions that directly target pathogenic proteins in order to change the course of devastating diseases. At Prothena, our success is driven by our people. We are dedicated to attracting individuals who share our vision to improve human health by putting patients first. Our shared humanity drives a passionate and unwavering commitment to apply high scientific rigor toward developing innovative new therapies for patients. We have ambitious goals and take every aspect of our mission seriously, while enjoying the journey. Our values connect us – you will see and feel them come to life in all we do – together.
Year Founded
2012
Social Media
Linkedin
Industry
Biotechnology Research, Scientific Research and Development Services, Services
HQ Location
77 Sir John Rogerson's Quay, Block C Grand Canal Docklands Dublin, 2 D02 T804, IE
Keywords
stem cell transplantwalk testform health survey
Discover More About Cleveland Clinic

Find verified contacts of Radhika Tripuraneni in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.